CD3+ CD56+ EBER1+ atypical extraosseous plasmacytoma of the nasal cavity

被引:4
|
作者
Ando, Yayoi [1 ,2 ]
Maeshima, Akiko Miyagi [1 ]
Fukuhara, Suguru [2 ]
Makita, Shinichi [2 ]
Munakata, Wataru [2 ]
Suzuki, Tatsuya [2 ]
Maruyama, Dai [2 ]
Taniguchi, Hirokazu [1 ]
Izutsu, Koji [2 ]
机构
[1] Natl Canc Ctr, Div Pathol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Dept Hematol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan
关键词
CD3; CD56; Epstein-Barr virus; Nasal cavity; Plasmacytoma; EPSTEIN-BARR-VIRUS; PLASMABLASTIC LYMPHOMA; SOLITARY PLASMACYTOMA; IMMUNOCOMPETENT; DIAGNOSIS; NEOPLASMS; FEATURES; TUMORS;
D O I
10.1007/s12185-018-2438-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We present a case of atypical extraosseous plasmacytoma (EP) with a plasmablastic morphology and CD3(+) CD56(+) Epstein-Barr virus-encoded RNA-1 (EBER1)(+) phenotypes of the nasal cavity. A 51-year-old male attended a local hospital with a tumor located in his left nasal cavity that was histologically diagnosed as extranodal NK/T cell lymphoma, nasal type. We reviewed the specimens and re-biopsied the tumor, and confirmed that the tumor was positive for CD3, CD56, and EBER1; however, the tumor showed a plasmablastic morphology without necrosis and angiocentricity, and was positive for CD138, but negative for CD20 and PAX5. Given a plasmablastic morphology and EBER1 positivity, but a relatively low Ki67 index (30%), we diagnosed the case as atypical EP. The CHOP regimen was administered and complete remission achieved. This case indicated that EP should be considered as a differential diagnosis even when a tumor shows large cell morphology and is positive for CD3, CD56, and EBER1.
引用
收藏
页码:344 / 347
页数:4
相关论文
共 50 条
  • [41] RELATIONSHIP OF LARGE AND SMALL CD3- CD56+ LYMPHOCYTES MEDIATING NK-ASSOCIATED ACTIVITIES
    ORTALDO, JR
    WINKLERPICKETT, R
    KOPP, W
    KAWASAKI, A
    NAGASHIMA, K
    OKUMURA, K
    YAGITA, H
    BACH, FH
    JOURNAL OF LEUKOCYTE BIOLOGY, 1992, 52 (03) : 287 - 295
  • [42] ISOLATION OF VERY PURE LYMPHOID (CD3+, CD19+OR CD56+) AND MYELOID (CD15+OR CD33/CD66B+) CELL SUBSETS IN AS LITTLE AS 15 MINUTES FOR USE IN LINEAGE-SPECIFIC CHIMERISM ANALYSIS
    McQueen, Karina
    Dixon, Jason
    Jang, Yuree
    Maestre-Batle, Danay
    Antignano, Frann
    Peters, Carrie
    Thomas, Terry
    HLA, 2017, 89 (06) : 433 - 433
  • [43] Decreased Interferon γ Production in CD3+ and CD3-CD56+ Lymphocyte Subsets in Metastatic Regional Lymph Nodes of Melanoma Patients
    Vuletic, Ana
    Jovanic, Irena
    Jurisic, Vladimir
    Milovanovic, Zorka
    Nikolic, Srdan
    Spurnic, Igor
    Konjevic, Gordana
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (04) : 1109 - 1114
  • [44] Non-nasal CD56+ lymphoma/leukemia: An analysis of 42 cases of an aggressive neoplasm.
    Chan, JKC
    Sin, VC
    Wong, KF
    Ng, CS
    Tsang, WYW
    Chan, CH
    Lau, WH
    LABORATORY INVESTIGATION, 1997, 76 (01) : 708 - 708
  • [45] Sunitinib Indirectly Enhanced Anti-Tumor Cytotoxicity of Cytokine-Induced Killer Cells and CD3+ CD56+ Subset through the Co-Culturing Dendritic Cells
    Wongkajornsilp, Adisak
    Wamanuttajinda, Valla
    Kasetsinsombat, Kanda
    Duangsa-ard, Sunisa
    Sa-ngiamsuntorn, Khanit
    Hongeng, Suradej
    Maneechotesuwan, Kittipong
    PLOS ONE, 2013, 8 (11):
  • [46] Five children and seven adults with CD7+ CD56+ CD3- acute natural killer cell leukemia
    Spahn, G
    Sperling, C
    Büchner, T
    Creutzig, U
    Schlegelberger, B
    Harbott, J
    Döhner, H
    Dörken, B
    Ludwig, WD
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 114 - 114
  • [47] Cytolytic activity of CD56+, but not CD56-, MUC1-specific Vα24 NKT cells is ICAM-dependent
    Wajchman, HJ
    Kokko, K
    Dombrowski, KE
    FASEB JOURNAL, 2003, 17 (07): : C76 - C76
  • [48] Atypical CD3+ CD4low cell population in a boy with fatal EBV-infection
    Gruber, R
    Krauss-Etschmann, S
    Jäger, G
    Belohradsky, BH
    Koletzko, S
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1999, 118 (01) : 74 - 78
  • [49] Quantities of CD3+, CD8+and CD56+lymphocytes decline in breast cancer recurrences while CD4+remain similar
    Mutka, Minna
    Joensuu, Kristiina
    Eray, Mine
    Heikkila, Paivi
    DIAGNOSTIC PATHOLOGY, 2023, 18 (01)
  • [50] 免疫表型为CD8+,CD4-,CD56+的蕈样肉芽肿1例
    甄希
    于建斌
    张江安
    徐文博
    庞丽娜
    曹瑞祥
    中国皮肤性病学杂志, 2010, 24 (12) : 1135 - 1137